comparemela.com

Latest Breaking News On - Turning point therapeutics - Page 25 : comparemela.com

Bristol Myers Squibb (BMY) Q2 2022 Earnings Call Transcript

BMY earnings call for the period ending June 30, 2022.

United kingdomUnited statesAndrew baumRaymond jamesChris boernerChris shibutaniTerence flynn morgan stanleyTerence flynnGiovanni caforioAndrew baum citiGeoff meachamCarter gould barclaysSteve scala cowenSeamus fernandez guggenheimFucosylated probodyMatthew phipps william blair

Earnings season continues: BMS revenue inches up, Teva lowers outlook

BMS's revenue climbs slightly; Teva also provided an update on its $4.25 billion opioid settlement agreement.

United statesGiovanni caforioBristol myers squibbTeva pharmaceuticalsTurning point therapeuticsNative american

HBM Healthcare Investments Quarterly Report June 2022

HBM Healthcare Investments AG / Key word(s): Quarter Results HBM Healthcare Investments Quarterly Report June 2022 22-Jul-2022 / 06:45 CET/CE.

United statesArcutis biotherapeuticsBristol myers squibbBiohaven pharmaceuticalsWorld health care indexDrug administrationHealth care indexNasdaq biotechnology indexSierra oncologyTurning point therapeuticsTurning pointY mabs therapeuticsQuarterly report june

How These Acquisitions Are Changing the Outlook for Bristol Myers Squibb

The company is reshaping and expanding its oncology portfolio.

Bristol myerBristol myers squibbBristol myersDrug administrationContingent value rightTurning point therapeuticsCentury therapeuticsTurning point

Bristol Myers Squibb Announces Extension of Turning Point Tender Offer

Press release content from Business Wire. The AP news staff was not involved in its creation.

New yorkUnited statesBristol myers squibbOffice of the corporateEquiniti trust companyExchange commissionPoint therapeutics incSecurities exchangeRhumba merger sub incMyers squibbRhumba merger subTurning point therapeuticsTurning pointEastern timeTrust companyCommon stock

vimarsana © 2020. All Rights Reserved.